Cathepsin S as an immunomodulator in lung cancer

Read full text Summarise with VIRAT
Authors: Roisin Morelli
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cathepsin S (CatS), a cysteine protease, plays a vital role in the cleavage of the Major Histocompatibility Complex II (MHC Class II) invariant chain for antigen processing and presentation to CD4+ helper T-cells. In chronic inflammatory lung conditions and certain cancers, CatS is highly upregulated. Both tumour cell and macrophage-derived CatS has been shown to promote tumourigenesis. In the tumour microenvironment (TME), infiltrating tumour-associated macrophages (TAMs) with a pro-tumour phenotype have been cited as a key cell source of CatS, and it has been shown that CatS plays a role in maintaining this phenotype. However, little data exists on the role of CatS in lung adenocarcinoma (LUAD), therefore, this study aimed to determine the functionality of CatS in LUAD by pharmacological and genetic ablation approaches. Thesis is embargoed until 31 December 2028.

Fields of Study & Subjects

Protease and Inhibitor Mechanisms Immune cells in cancer Peptidase Inhibition and Analysis

Publication details

Journal / source
Research Portal (Queen's University Belfast)
Publication date
1 October 2026
Language
EN
Document type
Thesis